课题基金 / 基金详情

Novel anti-viral protective clothing for healthcare applications

Novel anti-viral protective clothing for healthcare applications
用于医疗保健应用的新型抗病毒防护服
批准号:
60693
负责人:
金额:
$9.55万
依托单位:
依托单位国家:
英国
项目类别:
Feasibility Studies
财政年份:
2020
资助国家:
英国
项目状态:
已结题
起止时间:
2020 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
2Dtronics will create protective clothing for front-line workers and others in the UK's battle against COVID-19 as well as for further virus outbreaks. The company will use textile engineering techniques to produce a robust and effective anti-viral coating which can be applied to a range of protective garments worn by medical and support staffs.We will use our background in textiles, and experience in advanced materials to combine known anti-viral materials in a novel formulation which will improve effectiveness and increase durability. We will use modern textile production techniques to produce a fabric which can be formed into high performance protective clothing rapidly and at a low cost.Our mission is to reduce the rate of person to person transmission by providing front-line healthcare workers with protective clothing that can kill viruses on contact in the dynamic healthcare setting in which front line workers must do their jobs.During the extension for impact period, our objective is to perform commercialisation activities of the protective clothing developed from this project, which will create positive societal, economical and environmental impacts of our project. We expect to validate our business models with potential customers to enable rapid transition of the technology to the market.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
基于spA-Gel负载Anti-HMGB1原位靶向免疫耐受的猪胰岛类器官移植研
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    程瑶
  • 依托单位:
TKIs氘代化修饰通过促进HCC铁死亡增强免疫原性并增敏anti-PD-1治疗的机制研究
  • 批准号:
    JCZRQN202500319
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
肺癌外周血淋巴细胞亚群预测anti-PD1/PDL1疗效的鉴定及应用研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    仇凤启
  • 依托单位:
构建α-突触核蛋白特异性CAR-Treg治疗抗NMDAR脑炎的研究